Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation

Nadia Zghoul,1 Nada Alam-Eldin,1 Ivan Tong Mak,2 Burton Silver,3 William B Weglicki2 1Clinical Research Unit, Dasman Diabetes Institute, Dasman, Kuwait, Kuwait; 2Department of Biochemistry and Molecular Medicine, George Washington University, Washington, DC, USA; 3Intracellular Diagnostics, Inc.&...

Full description

Bibliographic Details
Main Authors: Zghoul N, Alam-Eldin N, Mak IT, Silver B, Weglicki WB
Format: Article
Language:English
Published: Dove Medical Press 2018-08-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/hypomagnesemia-in-diabetes-patients-comparison-of-serum-and-intracellu-peer-reviewed-article-DMSO
_version_ 1797712228066000896
author Zghoul N
Alam-Eldin N
Mak IT
Silver B
Weglicki WB
author_facet Zghoul N
Alam-Eldin N
Mak IT
Silver B
Weglicki WB
author_sort Zghoul N
collection DOAJ
description Nadia Zghoul,1 Nada Alam-Eldin,1 Ivan Tong Mak,2 Burton Silver,3 William B Weglicki2 1Clinical Research Unit, Dasman Diabetes Institute, Dasman, Kuwait, Kuwait; 2Department of Biochemistry and Molecular Medicine, George Washington University, Washington, DC, USA; 3Intracellular Diagnostics, Inc.®, Medford, OR, USA Purpose: In this clinical trial, we assessed the efficacy of magnesium (Mg) supplementation in hypomagnesemic type 2 diabetes patients in restoring serum and intracellular Mg levels. The study had two coprimary end points: the change in serum and intracellular Mg level between baseline and after 3 months of supplementation. We compared the efficacy with regard to lowering hemoglobin A1c (HbA1c), C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), and 8-isoprostane as secondary end points. Patients and methods: In an open-label trial, 47 hypomagnesemic type 2 diabetes patients were administered 336 mg Mg daily. At baseline and after 3 months, serum, cellular Mg, and inflammation biomarkers were measured. For intracellular Mg levels, sublingual epithelial cells were analyzed by analytical scanning electron microscopy using computerized elemental X-ray analysis. Blood samples were analyzed for Mg, creatinine, HbA1c, and CRP. Systemic inflammatory markers including TNF-α and the oxidative stress marker 8-isoprostane were determined using enzyme-linked immunosorbent assay. Results: Mg supplementation significantly increased the intracellular and serum levels. Statistically clinical improvement in HbA1c and CRP levels was not observed, but significant decreases in TNF-α as well as in 8-isoprostane were found. Conclusion: A feasible clinical method for the assessment of intracellular Mg was demonstrated in tissue samples obtained noninvasively, providing evidence for potential clinical translation of this method to routinely determine intracellular Mg concentration. Keywords: hypomagnesemia, type 2 diabetes, intracellular magnesium, elemental X-ray analysis
first_indexed 2024-03-12T07:18:34Z
format Article
id doaj.art-d12247186ff844e7a723ab67d0dec076
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-03-12T07:18:34Z
publishDate 2018-08-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-d12247186ff844e7a723ab67d0dec0762023-09-02T22:39:33ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072018-08-01Volume 1138940039656Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammationZghoul NAlam-Eldin NMak ITSilver BWeglicki WBNadia Zghoul,1 Nada Alam-Eldin,1 Ivan Tong Mak,2 Burton Silver,3 William B Weglicki2 1Clinical Research Unit, Dasman Diabetes Institute, Dasman, Kuwait, Kuwait; 2Department of Biochemistry and Molecular Medicine, George Washington University, Washington, DC, USA; 3Intracellular Diagnostics, Inc.®, Medford, OR, USA Purpose: In this clinical trial, we assessed the efficacy of magnesium (Mg) supplementation in hypomagnesemic type 2 diabetes patients in restoring serum and intracellular Mg levels. The study had two coprimary end points: the change in serum and intracellular Mg level between baseline and after 3 months of supplementation. We compared the efficacy with regard to lowering hemoglobin A1c (HbA1c), C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), and 8-isoprostane as secondary end points. Patients and methods: In an open-label trial, 47 hypomagnesemic type 2 diabetes patients were administered 336 mg Mg daily. At baseline and after 3 months, serum, cellular Mg, and inflammation biomarkers were measured. For intracellular Mg levels, sublingual epithelial cells were analyzed by analytical scanning electron microscopy using computerized elemental X-ray analysis. Blood samples were analyzed for Mg, creatinine, HbA1c, and CRP. Systemic inflammatory markers including TNF-α and the oxidative stress marker 8-isoprostane were determined using enzyme-linked immunosorbent assay. Results: Mg supplementation significantly increased the intracellular and serum levels. Statistically clinical improvement in HbA1c and CRP levels was not observed, but significant decreases in TNF-α as well as in 8-isoprostane were found. Conclusion: A feasible clinical method for the assessment of intracellular Mg was demonstrated in tissue samples obtained noninvasively, providing evidence for potential clinical translation of this method to routinely determine intracellular Mg concentration. Keywords: hypomagnesemia, type 2 diabetes, intracellular magnesium, elemental X-ray analysishttps://www.dovepress.com/hypomagnesemia-in-diabetes-patients-comparison-of-serum-and-intracellu-peer-reviewed-article-DMSOHypomagnesemiatype 2 diabetesintracellular magnesiumelemental X ray analysis
spellingShingle Zghoul N
Alam-Eldin N
Mak IT
Silver B
Weglicki WB
Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation
Diabetes, Metabolic Syndrome and Obesity
Hypomagnesemia
type 2 diabetes
intracellular magnesium
elemental X ray analysis
title Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation
title_full Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation
title_fullStr Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation
title_full_unstemmed Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation
title_short Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation
title_sort hypomagnesemia in diabetes patients comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation
topic Hypomagnesemia
type 2 diabetes
intracellular magnesium
elemental X ray analysis
url https://www.dovepress.com/hypomagnesemia-in-diabetes-patients-comparison-of-serum-and-intracellu-peer-reviewed-article-DMSO
work_keys_str_mv AT zghouln hypomagnesemiaindiabetespatientscomparisonofserumandintracellularmeasurementofresponsestomagnesiumsupplementationanditsroleininflammation
AT alameldinn hypomagnesemiaindiabetespatientscomparisonofserumandintracellularmeasurementofresponsestomagnesiumsupplementationanditsroleininflammation
AT makit hypomagnesemiaindiabetespatientscomparisonofserumandintracellularmeasurementofresponsestomagnesiumsupplementationanditsroleininflammation
AT silverb hypomagnesemiaindiabetespatientscomparisonofserumandintracellularmeasurementofresponsestomagnesiumsupplementationanditsroleininflammation
AT weglickiwb hypomagnesemiaindiabetespatientscomparisonofserumandintracellularmeasurementofresponsestomagnesiumsupplementationanditsroleininflammation